A retrospective study of alemtuzumab level, t-cell chimerism and graft-versus-host disease using intermediate dose alemtuzumab for matched related and matched unrelated reduced-intensity transplantation

被引：0
|
作者：
Morgan, T. [1 ]
Cope, W. [2 ]
Charlton, A. [2 ]
Spence, L. [2 ]
Bigley, V. [1 ]
Groves, N. [3 ]
Hale, G. [3 ]
Pagan, S. [1 ]
Turner, B. [1 ]
Jones, G. [2 ]
Jackson, G. [2 ]
Dickinson, A. [1 ]
Collin, M. [1 ]
机构：
[1] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[3] BioAnaLab Ltd, Oxford, England
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [1] A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.
    Charlton, Andrew
    Spence, Laura
    Bigley, Venetia
    Groves, Natasha
    Hale, Geoff
    Pagan, Sarah
    Turner, Brie E.
    Jones, Gail
    Jackson, Graham H.
    Dickinson, Anne M.
    Collin, Matthew
    [J]. BLOOD, 2009, 114 (22) : 1293 - 1293
  • [2] Low-dose alemtuzumab versus standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation: a matched pair analysis
    Busemann, C.
    Neumann, T.
    Schulze, M.
    Klenner, A.
    Thiele, T.
    Greinacher, A.
    Doelken, G.
    Krueger, W. H.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S219 - S219
  • [3] A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants
    Jardine, Laura
    Publicover, Amy
    Bigley, Venetia
    Hale, Geoff
    Pearce, Kim
    Dickinson, Anne
    Jackson, Graham
    Collin, Matthew
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) : 874 - 881
  • [4] OPTIMIZATION OF ALEMTUZUMAB DOSE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR REDUCED INTENSITY TRANSPLANTATION FROM UNRELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    Gupta, V
    Xu, W.
    Sutherland, R.
    Kamel-Reid, S.
    Kuruvilla, J.
    Loach, D.
    Lipton, J. H.
    Messner, H. A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 124 - 125
  • [5] LOW DOSE ALEMTUZUMAB FOR GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING DONOR HEMATOPOIETIC CELL TRANSPLANTATION
    Liga, Maria
    Tsokanas, Dimitrios
    Sagiadinou, Elefteria
    Triantafyllou, Evangelia
    Valera, Krisela
    Christopoulou, Anastasia
    Zacharioudaki, Vassiliki
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 367 - 368
  • [6] Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation—a matched pair analysis
    Christoph Busemann
    Thomas Neumann
    Meike Schulze
    Anne Klenner
    Thomas Thiele
    Andreas Greinacher
    Gottfried Dölken
    William H. Krüger
    [J]. Annals of Hematology, 2013, 92 : 945 - 952
  • [7] Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed
    Dodero, A
    Carrabba, M
    Milani, R
    Rizzo, E
    Raganato, A
    Montefusco, V
    Farina, L
    Milanesi, M
    Longoni, P
    Carlo-Stella, C
    Corradini, P
    [J]. EXPERIMENTAL HEMATOLOGY, 2005, 33 (08) : 920 - 927
  • [8] Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation-a matched pair analysis
    Busemann, Christoph
    Neumann, Thomas
    Schulze, Meike
    Klenner, Anne
    Thiele, Thomas
    Greinacher, Andreas
    Doelken, Gottfried
    Krueger, William H.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (07) : 945 - 952
  • [9] Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies
    Kanda, Junya
    Long, Gwynn D.
    Gasparetto, Cristina
    Horwitz, Mitchell E.
    Sullivan, Keith M.
    Chute, John P.
    Morris, Ashley
    Shafique, Michael
    Li, Zhiguo
    Chao, Nelson J.
    Rizzieri, David A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 257 - 263
  • [10] Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab
    Chen, Xiaohua
    Hill, Memphis
    Vander Lugt, Mark
    Escolar, Maria
    Fang, Zhou
    Chen, Wei
    Szabolcs, Paul
    [J]. CYTOTHERAPY, 2020, 22 (03) : 149 - 157
12345